Stock page
Aspargo Labs Inc (AAGO)
Aspargo Labs Inc is a commercial stage, specialty pharmaceutical and med-tech company focused on designing, developing and marketing oral liquid suspension formulations of oral solid dose Rx and OTC medications for administration in personalized, digitally connected, electronic drug delivery devices and accompanying mobile apps. Its first commercial product, Sildenafil Oral Suspension is a proprietary oral spray liquid suspension formulation of sildenafil citrate, the active ingredient in VIAGRA, indicated for the treatment of erectile dysfunction (ED).
Quote snapshot
$0.00
Daily change: —
ExchangeNYSE
Updated2026-05-09T04:30:29.074681Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|